Literature DB >> 19266211

Influence of bone morphogenetic protein-2 on spiral ganglion neurite growth in vitro.

Stefan Volkenstein1, D Brors, S Hansen, A Minovi, M Laub, H P Jennissen, S Dazert, A Neumann.   

Abstract

Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a growth factor of the transforming growth factor-beta superfamily. Members of this protein family are involved in the development of various mammalian tissues, including the inner ear. As their notations indicate, they also have well-known effects on bone formation and regeneration. In this study, we examined the influence of rhBMP-2 on spiral ganglion (SG) neurite growth in vitro and showed the presence of its most preferred receptor BMPR-IB in spiral ganglion cells both in vitro and in vivo. SG explants of postnatal day 4 rats were analysed for neurite length and number after organotypical cell culture for 72 h, fixation and immunolabeling. Different concentrations of rhBMP-2 were used in a serum-free culture media. Neurite growth was compared with control groups that lacked stimulative effects; with neutrophin-3 (NT-3), which is a well-established positive stimulus on neurite length and number; and with combinations of these parameters. The results display that neurite number and total neurite length per explant in particular concentrations of rhBMP-2 increased by a maximum factor of two, while the mean neurite length was not affected. NT-3 demonstrated a much more potent effect, delivering a maximum increase of a factor of five. Furthermore, a combination of both growth factors shows a predominant effect on NT-3. Immunohistological detection of BMPR-IB was successful both in cell culture explants and in paraffin-embedded sections of animals of different ages. The results show that rhBMP-2 is, among other growth factors, a positive stimulus for SG neurite growth in vitro. Most growth factors are unstable and cannot be attached to surfaces without loss of their biological function. In contrast, rhBMP-2 can be attached to metal surfaces without loss of activity. Our findings suggest in vivo studies and a future clinical application of rhBMP-2 in cochlear implant technology to improve the tissue/electrode interface.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266211     DOI: 10.1007/s00405-009-0930-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  45 in total

1.  A rapid method for semi-quantitative analysis of neurite outgrowth from chick DRG explants using image analysis.

Authors:  J Bilsland; M Rigby; L Young; S Harper
Journal:  J Neurosci Methods       Date:  1999-10-15       Impact factor: 2.390

Review 2.  Ageing and hearing loss.

Authors:  X Z Liu; D Yan
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

3.  Development of a drug delivery device: using the femtosecond laser to modify cochlear implant electrodes.

Authors:  T Stöver; G Paasche; T Lenarz; T Ripken; P Breitenfeld; H Lubatschowski; T Fabian
Journal:  Cochlear Implants Int       Date:  2007-03

4.  NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells.

Authors:  H Staecker; R Kopke; B Malgrange; P Lefebvre; T R Van de Water
Journal:  Neuroreport       Date:  1996-03-22       Impact factor: 1.837

Review 5.  Strategies to preserve or regenerate spiral ganglion neurons.

Authors:  Pamela C Roehm; Marlan R Hansen
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-10       Impact factor: 2.064

6.  BMP-signaling regulates the generation of hair-cells.

Authors:  Cristina Pujades; Andrés Kamaid; Berta Alsina; Fernando Giraldez
Journal:  Dev Biol       Date:  2006-02-03       Impact factor: 3.582

7.  Culture conditions determine the prevalence of bipolar and monopolar neurons in cultures of dissociated spiral ganglion.

Authors:  D S Whitlon; M Grover; J Tristano; T Williams; M T Coulson
Journal:  Neuroscience       Date:  2007-02-27       Impact factor: 3.590

Review 8.  [Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics].

Authors:  J Lautermann; N Dehne; J Schacht; K Jahnke
Journal:  Laryngorhinootologie       Date:  2004-05       Impact factor: 1.057

9.  Cochlear implant channel separation and its influence on speech perception--implications for a new electrode design.

Authors:  Christoph Arnoldner; Dominik Riss; Wolf-Dieter Baumgartner; Alexandra Kaider; Jafar-Sasan Hamzavi
Journal:  Audiol Neurootol       Date:  2007-05-23       Impact factor: 1.854

10.  Survival, synaptogenesis, and regeneration of adult mouse spiral ganglion neurons in vitro.

Authors:  Dongguang Wei; Zhe Jin; Leif Järlebark; Eric Scarfone; Mats Ulfendahl
Journal:  Dev Neurobiol       Date:  2007-01       Impact factor: 3.964

View more
  4 in total

1.  Oriented collagen as a potential cochlear implant electrode surface coating to achieve directed neurite outgrowth.

Authors:  Stefan Volkenstein; John E Kirkwood; Edwina Lai; Stefan Dazert; Gerald G Fuller; Stefan Heller
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-28       Impact factor: 2.503

2.  Pleiotrophin increases neurite length and number of spiral ganglion neurons in vitro.

Authors:  Sebastian Bertram; Lars Roll; Jacqueline Reinhard; Katharina Groß; Stefan Dazert; Andreas Faissner; Stefan Volkenstein
Journal:  Exp Brain Res       Date:  2019-09-12       Impact factor: 1.972

3.  Bone morphogenetic protein 4 promotes the survival and preserves the structure of flow-sorted Bhlhb5+ cochlear spiral ganglion neurons in vitro.

Authors:  Muhammad Waqas; Shan Sun; Chuanyin Xuan; Qiaojun Fang; Xiaoli Zhang; Irum-Us Islam; Jieyu Qi; Shasha Zhang; Xia Gao; Mingliang Tang; Haibo Shi; Huawei Li; Renjie Chai
Journal:  Sci Rep       Date:  2017-06-14       Impact factor: 4.379

4.  Novel High Content Screen Detects Compounds That Promote Neurite Regeneration from Cochlear Spiral Ganglion Neurons.

Authors:  Donna S Whitlon; Mary Grover; Sara F Dunne; Sonja Richter; Chi-Hao Luan; Claus-Peter Richter
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.